Hsiao-Hsuan Kuo

Hsiao-Hsuan Kuo

Auto-generated profile, based on publicly available information

Hsiao-Hsuan Kuo

Moderna Inc., Cambridge, MA, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
BCBina Choi
Bina Choi
MCManish C. Choudhary
Manish C. Choudhary
JRJames Regan
James Regan
JSJeffrey A. Sparks
Jeffrey A. Sparks
RPRobert F. Padera
Robert F. Padera
JLJonathan Z. Li
Jonathan Z. Li
A 45-year-old man with severe antiphospholipid syndrome complicated by diffuse alveolar hemorrhage,1 who was receiving anticoagulation therapy, glucocorticoids, cyclophosphamide, and intermittent rituximab and eculizumab, was admitted to the hospital with fever (Fig. S1 in the Supplementary Appendix, available with the full text of this letter at NEJM.org). On day 0, Covid-19 was diagnosed by SARS-CoV-2 reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assay of a nasopharyngeal swab specimen, and the patient received a 5-day course of remdesivir (Fig. S2). Glucocorticoid doses were increased because of suspected diffuse alveolar hemorrhage. He was discharged on day 5 without a need for supplemental oxygen.

1 October 2020 in Cell
Verified
Journal Article
Closed access
NKNaoki Kaneko
Naoki Kaneko
HKHsiao-Hsuan Kuo
Hsiao-Hsuan Kuo
JBJulie Boucau
Julie Boucau
JFJocelyn R. Farmer
Jocelyn R. Farmer
HAHugues Allard-Chamard
Hugues Allard-Chamard
SPShiv Pillai
Shiv Pillai

23 October 2026 in Science Advances
Verified
Journal Article
Open access
ADAnthony DiPiazza
Anthony DiPiazza
EMEmily Marcisak
Emily Marcisak
WYWen-Han Yu
Wen-Han Yu
DMDaniel Makrinos
Daniel Makrinos
HKHsiao-Hsuan Kuo
Hsiao-Hsuan Kuo
YSYanbo Sun
Yanbo Sun
Respiratory syncytial virus (RSV) remains a health threat, particularly for infants, older adults, and immunocompromised individuals. Although neutralizing antibodies can help limit infection and viral replication, T cells are essential for reducing disease severity. Assessment of age-related declines in T cell function are important for vaccine evaluation. We used intracellular cytokine staining, activation-induced marker, and Meso Scale Discovery assays and single-cell multiomic profiling to evaluate RSV vaccine mRNA-1345 responses in younger and older adults. mRNA-1345 induced comparable CD4 + and CD8 + T cell responses in both cohorts, with CD4 + responses persisting for 24 months. The CD4 + response was strongly T helper 1 (T H 1)–polarized, with increased interferon-γ, interleukin-2, and tumor necrosis factor–α and minimal T H 2 cytokines. Both CD4 + and CD8 + T cells showed increased polyfunctionality that remained elevated at 2 years. Single-cell and T cell receptor repertoire analyses showed similar Pre-F–specific phenotypes, transcriptional profiles, and clonal overlap across age groups, supporting robust, durable cellular immunity after mRNA-1345 vaccination. These findings indicate shared vaccine-elicited T cell immunity in adults.